These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38031996)

  • 21. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
    Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F
    Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
    Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
    Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
    J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
    Natarajan V; Dudek SM; Jacobson JR; Moreno-Vinasco L; Huang LS; Abassi T; Mathew B; Zhao Y; Wang L; Bittman R; Weichselbaum R; Berdyshev E; Garcia JG
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):6-17. PubMed ID: 23449739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers.
    Camp SM; Marciniak A; Chiang ET; Garcia AN; Bittman R; Polt R; Perez RG; Dudek SM; Garcia JGN
    Pulm Circ; 2020; 10(1):. PubMed ID: 32095229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
    Wang L; Chiang ET; Simmons JT; Garcia JG; Dudek SM
    Eur Respir J; 2011 Jul; 38(1):78-88. PubMed ID: 21071472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
    Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
    Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
    Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
    Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720".
    Camp SM; Chiang ET; Sun C; Usatyuk PV; Bittman R; Natarajan V; Garcia JG; Dudek SM
    Chem Phys Lipids; 2016 Jan; 194():85-93. PubMed ID: 26496151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTY720 restores endothelial cell permeability induced by malaria sera.
    Oggungwan K; Glaharn S; Ampawong S; Krudsood S; Viriyavejakul P
    Sci Rep; 2018 Jul; 8(1):10959. PubMed ID: 30026484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S1P is associated with protection in human and experimental cerebral malaria.
    Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
    Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment.
    Wang Z; Kawabori M; Houkin K
    Curr Med Chem; 2020; 27(18):2979-2993. PubMed ID: 31785606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.
    Kalhori V; Magnusson M; Asghar MY; Pulli I; Törnquist K
    Endocr Relat Cancer; 2016 May; 23(5):457-68. PubMed ID: 26935838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.
    Brinkmann V; Cyster JG; Hla T
    Am J Transplant; 2004 Jul; 4(7):1019-25. PubMed ID: 15196057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
    Grenald SA; Doyle TM; Zhang H; Slosky LM; Chen Z; Largent-Milnes TM; Spiegel S; Vanderah TW; Salvemini D
    Pain; 2017 Sep; 158(9):1733-1742. PubMed ID: 28570482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insights into sphingosine-1-phosphate receptor activation.
    Yu L; He L; Gan B; Ti R; Xiao Q; Hu H; Zhu L; Wang S; Ren R
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117716119. PubMed ID: 35412894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema.
    Diab KJ; Adamowicz JJ; Kamocki K; Rush NI; Garrison J; Gu Y; Schweitzer KS; Skobeleva A; Rajashekhar G; Hubbard WC; Berdyshev EV; Petrache I
    Am J Respir Crit Care Med; 2010 Feb; 181(4):344-52. PubMed ID: 19965812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
    Brinkmann V
    Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of FTY720 as a sphingosine 1-phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms.
    Naseh M; Vatanparast J; Rafati A; Bayat M; Haghani M
    Brain Behav; 2021 Jun; 11(6):e02179. PubMed ID: 33969931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.